Detalhe da pesquisa
1.
A randomised evaluation of low-dose cytosine arabinoside plus lenalidomide versus single-agent low-dose cytosine arabinoside in older patients with acute myeloid leukaemia: Results from the LI-1 trial.
Br J Haematol
; 204(3): 871-876, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38016651
2.
Treatment intensification with FLAG-Ida may improve disease control in younger patients with secondary acute myeloid leukaemia: long-term follow up of the MRC AML15 trial.
Br J Haematol
; 196(6): 1344-1347, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34904225
3.
A randomised comparison of FLAG-Ida versus daunorubicin combined with clofarabine in relapsed or refractory acute myeloid leukaemia: Results from the UK NCRI AML17 trial.
Br J Haematol
; 198(3): 528-534, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35388465
4.
Outcomes of older patients aged 60 to 70 years undergoing reduced intensity transplant for acute myeloblastic leukemia: results of the NCRI acute myeloid leukemia 16 trial.
Haematologica
; 107(7): 1518-1527, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34647442
5.
Family caregiver ambassador support for caregivers of patients with newly diagnosed hematological cancer: a feasibility study.
Support Care Cancer
; 30(8): 6923-6935, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35543814
6.
Patient ambassador support in newly diagnosed patients with acute leukemia during treatment: a feasibility study.
Support Care Cancer
; 29(6): 3077-3089, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33051828
7.
Longitudinal symptom burden in adult patients with acute leukaemia participating in the PACE-AL randomised controlled exercise trial-an explorative analysis.
Eur J Cancer Care (Engl)
; 30(5): e13462, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34021510
8.
Patient ambassador support: Experiences of the mentorship between newly diagnosed patients with acute leukaemia and their patient ambassadors.
Eur J Cancer Care (Engl)
; 29(6): e13289, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32596951
9.
A randomized assessment of adding the kinase inhibitor lestaurtinib to first-line chemotherapy for FLT3-mutated AML.
Blood
; 129(9): 1143-1154, 2017 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27872058
10.
Systematic patient involvement for homebased outpatient administration of complex chemotherapy in acute leukemia and lymphoma.
Br J Haematol
; 181(5): 637-641, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29676445
11.
Addition of the mammalian target of rapamycin inhibitor, everolimus, to consolidation therapy in acute myeloid leukemia: experience from the UK NCRI AML17 trial.
Haematologica
; 103(10): 1654-1661, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29976746
12.
A randomized comparison of daunorubicin 90 mg/m2 vs 60 mg/m2 in AML induction: results from the UK NCRI AML17 trial in 1206 patients.
Blood
; 125(25): 3878-85, 2015 Jun 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-25833957
13.
Vosaroxin and vosaroxin plus low-dose Ara-C (LDAC) vs low-dose Ara-C alone in older patients with acute myeloid leukemia.
Blood
; 125(19): 2923-32, 2015 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-25805811
14.
An operational definition of primary refractory acute myeloid leukemia allowing early identification of patients who may benefit from allogeneic stem cell transplantation.
Haematologica
; 101(11): 1351-1358, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27540133
15.
Early warning and prevention of pneumonia in acute leukemia by patient education, spirometry, and positive expiratory pressure: A randomized controlled trial.
Am J Hematol
; 91(3): 271-6, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26661344
16.
Rituximab and dexamethasone vs dexamethasone monotherapy in newly diagnosed patients with primary immune thrombocytopenia.
Blood
; 121(11): 1976-81, 2013 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-23293082
17.
Optimized patient-trajectory for patients undergoing treatment with high-dose chemotherapy and autologous stem cell transplantation.
Acta Oncol
; 54(5): 750-8, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25761093
18.
Allelic methylation levels of the noncoding VTRNA2-1 located on chromosome 5q31.1 predict outcome in AML.
Blood
; 119(1): 206-16, 2012 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-22058117
19.
It is feasible and safe to stop specialized follow-up of asymptomatic lower risk chronic lymphocytic leukemia.
Blood Adv
; 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38429090
20.
Family caregiver quality of life and symptom burden in patients with hematological cancer: A Danish nationwide cross-sectional study.
Eur J Oncol Nurs
; 69: 102538, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38457934